close :

:

Forgotten your password?
 
Clinical Trials
Printable Version   Email to a friend

Tercica to Present at Investment Conferences

BRISBANE, Calif.--(BUSINESS WIRE)--Jul 2, 2007 - Tercica, Inc. (NASDAQ:TRCA) today announced that Company management will make an investment community presentation at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference at the Mandarin Oriental Hotel in New York on Wednesday, July 11, 2007 at 4:00 p.m. Eastern time (1:00 p.m. Pacific time).

A live audio webcast and slide presentation will be available via the Internet by visiting the Investors section of the Company's Web site at www.tercica.com. An archived presentation will be available on the Web site for 21 days.

Tercica also announced management's participation in the Pacific Growth Equities One on One Session: Focus on Cardiology and Metabolic Diseases conference being held at the Grand Hyatt Hotel in New York on Thursday, July 12, 2007. Company management will engage in a series of one-on-one and small-group meetings with portfolio managers and analysts during this full-day event.

About Tercica

Tercica is a biopharmaceutical company committed to improving endocrine health by partnering with the endocrine community to develop and commercialize new therapeutics for short stature and other metabolic disorders. For further information on Tercica, please visit www.tercica.com.

Contact

Investor and Media Contact:
Fredrik Wiklund
Senior Director, Investor Relations/Corporate Development
650-624-4992
fredrik.wiklund@tercica.com

Latest Clinical Trial Results...

Clinical Trial Results Archive

2008: Jan | Feb | Mar | Apr | May | Jun | Jul
2007: Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec
2006: Dec

More News Resources